This inventor holds 1 USPTO granted patent, plus 1 CIPO patent. Top assignee: Myostin Therapeutics Pty Ltd. Active years: 2012.
Company Filing History:
Years Active: 2012
Title: The Innovations of Robert Syndecombe Bower
Introduction
Robert Syndecombe Bower is a notable inventor based in Dunedin, New Zealand. He has made significant contributions to the field of biotechnology, particularly in the area of muscle strength enhancement. His work has implications for various applications, including therapeutic interventions for muscle-related conditions.
Latest Patents
Bower holds a patent for "Isolated polypeptides and methods of improving muscle strength." This patent describes an isolated recombinant polypeptide that exhibits myostatin antagonist activity. The invention includes a C-terminally truncated mature myostatin peptide, with truncation occurring at a position between amino acids 281 and 329, or a fragment, variant, or derivative thereof. This innovative approach has the potential to improve muscle strength significantly.
Career Highlights
Bower is associated with Myostin Therapeutics Pty Ltd, where he applies his expertise in developing novel therapeutic solutions. His work at the company focuses on advancing research in muscle strength and related health issues. With a patent portfolio that includes 1 patent, Bower has established himself as a key figure in his field.
Collaborations
Bower collaborates with talented professionals such as Victoria Siriett and Mridula Sharma. Their combined efforts contribute to the advancement of research and development in muscle-related therapies.
Conclusion
Robert Syndecombe Bower's innovative work in biotechnology, particularly through his patent on isolated polypeptides, showcases his commitment to improving muscle strength. His contributions are paving the way for future advancements in therapeutic applications.